Table 1.
Demographics
| All 4 doses of TXA | 1–3 Doses of TXA | No TXA | Overall | P value | |||
|---|---|---|---|---|---|---|---|
|
|
|||||||
| Number | 70 | 50 | 89 | 209 | ∗ | † | ‡ |
| Average Age (SD) | 79.0 (11.5) | 80.5 (11.1) | 82.3 (12.1) | 80.8 (11.7) | .779 | .650 | .186 |
| Female | 46 (66%) | 33 (66%) | 57 (64%) | 136 (65%) | .999 | .971 | .974 |
| Average BMI (SD) | 24.4 (4.1) | 23.5 (4.6) | 24.6 (4.6) | 24.3 (4.5) | .519 | .326 | .948 |
| Procedure Type | .212 | .286 | .958 | ||||
| IMN | 30 (43%) | 23 (46%) | 42 (47%) | 95 (45%) | |||
| Hemi | 30 (43%) | 13 (26%) | 28 (31%) | 71 (34%) | |||
| DHS | 4 (6%) | 8 (16%) | 8 (9%) | 20 10%) | |||
| CRPP | 3 (4%) | 6 (12%) | 7 (8%) | 16 (8%) | |||
| THA | 3 (4%) | 0 (0%) | 4 (5%) | 7 (3%) | |||
BMI = body mass index, CRPP = closed reduction percutaneous pinning, DHS = dynamic hip screw, hemi = hemiarthroplasty, IMN = intramedullary nail, THA = total hip arthroplasty, TXA = tranexamic acid.
Denotes the P value derived from a comparison between the group who received all 4 doses of TXA and the group who received between 1 and 3 doses of TXA.
Denotes the P value derived from a comparison between the group who received between 1 and 3 doses of TXA and the group who received no TXA.
Denotes the P value derived from a comparison between the group who received all 4 doses of TXA and the group who received no TXA.